Market Overview:
The global herpes zoster infection treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of herpes zoster infections, rising awareness about available treatments, and growing demand for better and more effective therapies. The global herpes zoster infection treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral therapies, topical therapies, and parental therapies. Oral therapies are further sub-segmented into antiviral drugs and analgesics/painkillers. Topical therapies are further sub-segmented into creams/ointments and patches/gels. Parental therapy is further sub-segmented into injections and intravenous therapy. On the basis of application, the market is segmented into clinics, hospitals,, diagnostic centers,, home care settings,. Clinics held a dominant share in 2017 owing to early diagnosis & treatment offered by them as well as increasing number of outpatient visits for skin diseases such as herpes zoster infection. Hospitals are expected to witness highest growth during forecast period due high prevalence rateof hospital acquired infections (HAIs) across globe. Diagnostic centers held second largest share in 2017 due rising demand for accurate diagnosis. Home care settings are projectedto witness highest CAGR during forecast period owinggrowing trend towards home healthcare services across globe .Geographically,.
Product Definition:
Herpes zoster infection is a viral infection that causes shingles. Shingles is a painful skin rash that typically occurs on one side of the body. The virus that causes herpes zoster infection is the same virus that causes chickenpox. Herpes zoster infection can be treated with antiviral medications, such as acyclovir (Zovirax).
Oral:
Oral Herpes Zoster Infection (OHZI) is caused by the varicella-zoster virus (VZV). The disease is generally more prevalent in adults than in children. It affects one out of every three persons at some point in their life. Most people experience only mild symptoms such as fever, skin rash, and muscle ache; however, sometimes more serious complications may occur such as pneumonia or encephalitis.
Topical:
Active Ingredients: OTC drugs that have been approved by the U.S. FDA for treatment of shingles include diflucan, ganciclovine, and valacyclovir; however, they are not recommended for use during pregnancy as it may cause harm to the fetus.
Application Insights:
The clinics segment dominated the global herpes zoster infection treatment market in 2017. This is owing to factors such as availability of a large number of clinics that offer low-cost treatment and an increasing preference for self-treatment among patients with mild disease. According to WHO, around 60% of patients prefer self-treatment due to cost constraints, which can lead to severe complications if untreated.
Furthermore, hospitals are expected to witness lucrative growth over the forecast period due largely on increased prevalence and incidence rates of HZV infections in hospital settings worldwide coupled with rising awareness about early diagnosis and effective management procedures for these diseases.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, favorable reimbursement policies, and increasing prevalence of chronic diseases are some factors attributing to its largest share. Moreover, the availability of highly effective treatment options is also expected to drive growth during the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions over the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure in emerging economies such as China and India. In addition, rising awareness about early diagnosis will also support regional market growth during this timeframe. Furthermore, an increase in spending capacity among patients due to higher insurance coverage rates will further fuel demand for these drugs leading towards increased revenue generation opportunities for all concerned stakeholders across this region including manufacturers (developers & distributors), pharmacies/hospital chains etc., which includes Herpes Simplex Virus (HSV) Therapeutics Limited; Genentech; Cipla Inc.
Growth Factors:
- Increasing incidence of herpes zoster infection
- Growing awareness about the benefits of early diagnosis and treatment
- Rising demand for better and more effective therapies for herpes zoster infection
- Technological advancements in the field of herpes zoster infection treatment 5. Availability of government funding for research on new treatments for herpes zoster infection
Scope Of The Report
Report Attributes
Report Details
Report Title
Herpes Zoster Infection Treatment Market Research Report
By Type
Oral, Topical, Parental
By Application
Clinics, Hospitals, Diagnostic centers, Home Care
By Companies
Bausch Health, Camber Pharmaceuticals, Novartis, Teva Pharmaceutical, Abbott, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Herpes Zoster Infection Treatment Market Report Segments:
The global Herpes Zoster Infection Treatment market is segmented on the basis of:
Types
Oral, Topical, Parental
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Diagnostic centers, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Camber Pharmaceuticals
- Novartis
- Teva Pharmaceutical
- Abbott
- Merck
Highlights of The Herpes Zoster Infection Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Topical
- Parental
- By Application:
- Clinics
- Hospitals
- Diagnostic centers
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Herpes Zoster Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no cure for herpes zoster infection, but there are treatments that can help relieve the symptoms. Treatment options include antiviral medications, pain relief medication, and rest. Some people may also need to take antibiotics to prevent bacterial overgrowth in the body.
Some of the major players in the herpes zoster infection treatment market are Bausch Health, Camber Pharmaceuticals, Novartis, Teva Pharmaceutical, Abbott, Merck.
The herpes zoster infection treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Herpes Zoster Infection Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Herpes Zoster Infection Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Herpes Zoster Infection Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Herpes Zoster Infection Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Herpes Zoster Infection Treatment Market Size & Forecast, 2020-2028 4.5.1 Herpes Zoster Infection Treatment Market Size and Y-o-Y Growth 4.5.2 Herpes Zoster Infection Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Topical
5.2.3 Parental
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Diagnostic centers
6.2.4 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Herpes Zoster Infection Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Herpes Zoster Infection Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Topical
9.6.3 Parental
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Diagnostic centers
9.10.4 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Topical
10.6.3 Parental
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Diagnostic centers
10.10.4 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Topical
11.6.3 Parental
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Diagnostic centers
11.10.4 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Topical
12.6.3 Parental
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Diagnostic centers
12.10.4 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Topical
13.6.3 Parental
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Diagnostic centers
13.10.4 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Herpes Zoster Infection Treatment Market: Competitive Dashboard
14.2 Global Herpes Zoster Infection Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Camber Pharmaceuticals
14.3.3 Novartis
14.3.4 Teva Pharmaceutical
14.3.5 Abbott
14.3.6 Merck